Citigroup Inc Celularity Inc Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.17 - $0.33 $22 - $42	-130 Reduced 91.55%	12 $0
Q2 2023 Aug 10, 2023	BUY	$0.42 - $0.81 $59 - $115	142 New	142 $0
Q4 2022 Feb 09, 2023	BUY	$1.08 - $2.35 $351 - $763	325 Added 19.04%	2,032 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.43 - $4.31 $39 - $396	92 Added 5.7%	1,707 $4,000
Q2 2022 Aug 10, 2022	SELL	$2.81 - $12.91 $7,075 - $32,507	-2,518 Reduced 60.92%	1,615 $5,000
Q1 2022 May 12, 2022	BUY	$3.81 - $9.79 $15,746 - $40,462	4,133 New	4,133 $36,000
Q4 2021 Feb 10, 2022	SELL	$4.64 - $7.46 $6,723 - $10,809	-1,449 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$6.05 - $12.15 $8,766 - $17,605	1,449 New	1,449 $10,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $296M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.